Abstract 337: Activation of Myocardial AMP-activated Protein Kinase by Metformin Prevents Progression of Heart Failure in Dogs; Involvement of eNOS Activation
H. Sasaki(Tohoku University), Masafumi Kitakaze(Hanwa Memorial Hospital), Naoki Mochizuki(National Cerebral and Cardiovascular Center), Masanori Asakura(National Cerebral and Cardiovascular Center), Jiyoong Kim(National Cerebral and Cardiovascular Center), Masashi Fujita(Kindai University), Kazuo Komamura, Kyung‐Duk Min(University of Virginia), Shoji Sanada(Kobe University Hospital), Seiji Takashima(The University of Osaka), Shin Ito(National Cerebral and Cardiovascular Center), Hiroyuki Takahama(Tohoku University), Tetsuo Minamino(Kagawa University), Hiroshi Asanuma(Meiji University of Integrative Medicine)
Cited by 0
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system
|Journal of Clinical Investigation|2007|1k
Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: Metalloproteinase inhibitors as a new therapy
|Nature Medicine|2002|722
Right Ventricular Function in Heart Failure With Preserved Ejection Fraction
|Circulation|2014|456
Cyclic AMP Potentiates Vascular Endothelial Cadherin-Mediated Cell-Cell Contact To Enhance Endothelial Barrier Function through an Epac-Rap1 Signaling Pathway
|Molecular and Cellular Biology|2004|414